F403-0197 Screening compound: 2-[6,7-dimethyl-10-oxo-2,3,10,10a-tetrahydrocyclopenta[b][1,5]benzodiazepin-9(1H)-yl]-N~1~-(4-fluoro-3-methylphenyl)acetamide

F403-0197 Screening compound: 2-[6,7-dimethyl-10-oxo-2,3,10,10a-tetrahydrocyclopenta[b][1,5]benzodiazepin-9(1H)-yl]-N~1~-(4-fluoro-3-methylphenyl)acetamide
F403-0197 Screening compound: 2-[6,7-dimethyl-10-oxo-2,3,10,10a-tetrahydrocyclopenta[b][1,5]benzodiazepin-9(1H)-yl]-N~1~-(4-fluoro-3-methylphenyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F403-0197
2-[6,7-dimethyl-10-oxo-2,3,10,10a-tetrahydrocyclopenta[b][1,5]benzodiazepin-9(1H)-yl]-N~1~-(4-fluoro-3-methylphenyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F403-0197

Molecular Formula

C23H24FN3O2 (C23 H24 FN3 O2)

Compound Name

2-[6,7-dimethyl-10-oxo-2,3,10,10a-tetrahydrocyclopenta[b][1,5]benzodiazepin-9(1H)-yl]-N~1~-(4-fluoro-3-methylphenyl)acetamide

IUPAC name

2-{1213-dimethyl-8-oxo-29-diazatricyclo[8.4.0.0^{37}]tetradeca-1(10)21113-tetraen-9-yl}-N-(4-fluoro-3-methylphenyl)acetamide

SMILES

Cc(c(C)c1)cc(N2CC(Nc(cc3)cc(C)c3F)=O)c1N=C(CCC1)C1C2=O

InChI

InChI=1S/C23H24FN3O2/c1-13-10-20-21(11-14(13)2)27(23(29)17-5-4-6-19(17)26-20)12-22(28)25-16-7-8-18(24)15(3)9-16/h7-11,17H,4-6,12H2,1-3H3,(H,25,28)/t17-/m0/s1

InChI Key

MGWFAPXFMSFDLI-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD27124846

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

393.46

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.235

Distribution Coefficient, logD

4.235

Water Solubility, LogSw

-4.38

Polar Surface Area

47.513

Acid Dissociation Constant (pKa)

10.89

Base Dissociation Constant (pKb)

0.29

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

34.80

F403-0197 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiparasite Library (23996 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Agro:
  • Agro
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with F403-0197 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F403-0197?
Check Price and Availability of F403-0197, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F403-0197 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F403-0197
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F403-0197
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F403-0197 available by request